XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K -April 04, 2024 at 06:04 am EDT
CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 REPORT OF INDEPENDENT REGISTERED PUBLIC...
Stay updated with breaking news from Infoworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 REPORT OF INDEPENDENT REGISTERED PUBLIC...
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail ...
The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- First Tin PLC - London-based, Germany and Australia-focused...
PHILADELPHIA and VANCOUVER, British Columbia, May 19, 2023 -- BriaCell Therapeutics Corp. , a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, is pleased... | May 19, 2023
A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone have a history of invasive breast cancer. And ...